This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Kurnit, Katherine
| Item Type | Name |
|
Concept
|
Adenosine
|
|
Concept
|
Breast Neoplasms
|
|
Concept
|
Antineoplastic Agents
|
|
Concept
|
Carcinoma, Squamous Cell
|
|
Concept
|
Animals
|
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
|
Concept
|
Cesarean Section
|
|
Concept
|
Adenocarcinoma, Mucinous
|
|
Concept
|
Biopsy
|
|
Concept
|
California
|
|
Concept
|
Fallopian Tube Neoplasms
|
|
Concept
|
Uterine Cervical Neoplasms
|
|
Concept
|
Genital Neoplasms, Female
|
|
Concept
|
Hyperthermia, Induced
|
|
Concept
|
Colorectal Neoplasms, Hereditary Nonpolyposis
|
|
Concept
|
Cross-Sectional Studies
|
|
Concept
|
Disease Susceptibility
|
|
Concept
|
Infant, Newborn
|
|
Concept
|
Obesity
|
|
Concept
|
Markov Chains
|
|
Concept
|
Indazoles
|
|
Concept
|
Mice, Inbred C57BL
|
|
Concept
|
Morbidity
|
|
Concept
|
Ovarian Neoplasms
|
|
Concept
|
Ovary
|
|
Concept
|
Phthalimides
|
|
Concept
|
Phenylurea Compounds
|
|
Concept
|
Pregnancy Outcome
|
|
Concept
|
Prostatic Neoplasms
|
|
Concept
|
Infant, Low Birth Weight
|
|
Concept
|
Risk Factors
|
|
Concept
|
Uterine Neoplasms
|
|
Concept
|
Quality of Life
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Sensitivity and Specificity
|
|
Concept
|
Texas
|
|
Concept
|
Humans
|
|
Concept
|
Body Mass Index
|
|
Concept
|
Statistics as Topic
|
|
Concept
|
United States
|
|
Concept
|
Risk Assessment
|
|
Concept
|
Disease Management
|
|
Concept
|
Vulvar Neoplasms
|
|
Concept
|
Baltimore
|
|
Concept
|
Prevalence
|
|
Concept
|
Lymph Nodes
|
|
Concept
|
Lymphatic Metastasis
|
|
Concept
|
Lymphocytes, Tumor-Infiltrating
|
|
Concept
|
Medical Oncology
|
|
Concept
|
Endometrial Neoplasms
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
Neoplasm Recurrence, Local
|
|
Concept
|
CD8-Positive T-Lymphocytes
|
|
Concept
|
Carcinoma, Endometrioid
|
|
Concept
|
beta Catenin
|
|
Concept
|
Decision Support Systems, Clinical
|
|
Concept
|
Angiogenesis Inhibitors
|
|
Concept
|
Peritoneal Neoplasms
|
|
Concept
|
Androgen Receptor Antagonists
|
|
Concept
|
B7-H1 Antigen
|
|
Concept
|
Internet
|
|
Concept
|
Quality-Adjusted Life Years
|
|
Concept
|
Antineoplastic Protocols
|
|
Concept
|
Mice
|
|
Concept
|
Transforming Growth Factor beta1
|
|
Concept
|
Data Mining
|
|
Concept
|
Antibodies, Monoclonal, Humanized
|
|
Concept
|
Colorectal Neoplasms
|
|
Concept
|
Reproducibility of Results
|
|
Concept
|
Survival Rate
|
|
Concept
|
DNA Methylation
|
|
Concept
|
Microsatellite Instability
|
|
Concept
|
Precision Medicine
|
|
Concept
|
Carcinosarcoma
|
|
Concept
|
Clinical Trials as Topic
|
|
Concept
|
Genetic Testing
|
|
Concept
|
Longitudinal Studies
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
5'-Nucleotidase
|
|
Concept
|
Cystadenocarcinoma, Serous
|
|
Concept
|
Disease-Free Survival
|
|
Concept
|
Genetic Predisposition to Disease
|
|
Concept
|
GPI-Linked Proteins
|
|
Academic Article
|
Moving From Mutation to Actionability.
|
|
Academic Article
|
Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer.
|
|
Academic Article
|
Immune checkpoint inhibitors in women with gynecologic cancers: Practical considerations.
|
|
Academic Article
|
Loss of CD73 shifts transforming growth factor-ß1 (TGF-ß1) from tumor suppressor to promoter in endometrial cancer.
|
|
Concept
|
Poly(ADP-ribose) Polymerase Inhibitors
|
|
Concept
|
MutL Protein Homolog 1
|
|
Concept
|
Prostatic Neoplasms, Castration-Resistant
|